Coronavirus Update: Will Moderna Really Demand Premium Price For COVID Vaccine?

Plus: Partners Launch Stem Cell Therapy Trial

There are reports that the US biotech is considering pricing its as-yet-unapproved mRNA-1273 at $25-30 a dose, a price which would double as both a prime and boost dose would be administered.

Foodbank_NY
Food bank queue in New York: The economic effects of the pandemic have plunged millions into poverty in the US and globally • Source: Shutterstock

Moderna, Inc. is reported to be planning to price its COVID-19 vaccine at $50 to $60 per two-part treatment, a much higher level than indicated by other frontrunners.

The Financial Times reported on 28 July that the US biotech is considering pricing its as-yet-unapproved mRNA-1273 at $25-30 a...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip